Nucleus Software's Q1 PAT fell 30.9% to ₹23.9 crore due to increased investments in expansion and talent. Revenue grew 6.4% QoQ to ₹210.4 crore, but margins compressed to 3.6%. The company highlighted a strong order book of ₹1,244 crore.
Nucleus Software Reports Q1 Results
Nucleus Software Exports Ltd reported Q1 consolidated revenue of ₹210.4 crore and Profit After Tax (PAT) of ₹23.9 crore.
Reader Takeaway: Strong order book faces margin pressure from growth investments.
What just happened
Nucleus Software's consolidated revenue for the quarter reached ₹210.4 crore, a 6.4% increase quarter-on-quarter (QoQ) and 3.4% year-on-year (YoY). Product revenue formed 83.9% of total revenue. However, Profit After Tax (PAT) declined by 30.9% QoQ and 32.2% YoY to ₹23.9 crore. EBITDA margin compressed significantly to 3.6%, down from historical averages. Operating expenses, including delivery costs and general administrative expenses, increased due to salary revisions, RSU impacts, and investments in global market expansion and AI.
Why this matters
The company is prioritizing long-term investments in AI and global market expansion, leading to short-term margin compression and a rise in operating expenses. While revenue shows growth, profitability is impacted. The increase in Days Sales Outstanding (DSO) to 63 days also signals a potential slowdown in cash realization.
The backstory
Nucleus Software has historically maintained EBITDA margins around 15%+. The current quarter's performance deviates from this trend as the company strategically invests in its product and AI capabilities and expands its global presence. A one-time event related to special capitalization with a major India-based client also impacted revenue performance in the domestic segment.
What changes now
Investors will be watching how effectively the company can convert its substantial order book into sustained revenue and improve profitability. The focus on long-term investments means that immediate financial returns might be subdued, requiring patience from shareholders.
Risks to watch
Key risks include the persistent margin compression, the rising DSO which could strain working capital, and execution risks associated with the long implementation cycles of its large order book. Normalizing operating expenses and achieving historical margin levels will be crucial.
Peer comparison
While specific peer data is not provided in the filing, software companies often face challenges balancing growth investments with profitability. The current margin levels for Nucleus Software are notably lower than its historical performance, suggesting a significant strategic shift or market pressure.
Context metrics (time-bound)
- Consolidated Revenue: ₹210.4 crore (Q1 FY27), up 6.4% QoQ.
- PAT: ₹23.9 crore (Q1 FY27), down 30.9% QoQ.
- EBITDA Margin: 3.6% (Q1 FY27).
- Order Book: ₹1,244 crore as of June 30, 2026.
- Cash and Cash Equivalents: ₹977.9 crore as of June 30, 2026.
- DSO: 63 days (Q1 FY27), up from 42 days (Q4 FY26).
What to track next
Investors should monitor the company's progress in converting its order book, the trend in operating expenses, and the trajectory of its EBITDA margins and DSO in the upcoming quarters. The success of its AI integration and global expansion strategies will be key indicators.
